BIUNDO, ROBERTA
 Distribuzione geografica
Continente #
NA - Nord America 2092
EU - Europa 411
AS - Asia 82
Continente sconosciuto - Info sul continente non disponibili 2
AF - Africa 1
Totale 2588
Nazione #
US - Stati Uniti d'America 2090
IT - Italia 237
CN - Cina 60
SE - Svezia 40
DE - Germania 39
FI - Finlandia 38
GB - Regno Unito 18
VN - Vietnam 14
NL - Olanda 11
FR - Francia 8
IE - Irlanda 7
ES - Italia 4
UA - Ucraina 4
SG - Singapore 3
CA - Canada 2
EU - Europa 2
JP - Giappone 2
NO - Norvegia 2
BG - Bulgaria 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
ID - Indonesia 1
IR - Iran 1
SA - Arabia Saudita 1
SC - Seychelles 1
Totale 2588
Città #
Fairfield 435
Chandler 214
Woodbridge 182
Cambridge 175
Ashburn 153
Houston 150
Seattle 148
Wilmington 122
Padova 83
Ann Arbor 76
San Diego 57
Princeton 47
Medford 44
Des Moines 32
Helsinki 27
Beijing 26
Roxbury 26
Rome 24
Milan 23
Boardman 15
Dong Ket 14
Nanjing 11
Legnaro 9
London 9
Dublin 7
Norwalk 7
San Donà di Piave 7
Rovigo 6
Nanchang 5
Shenyang 5
Brendola 4
Kharkiv 4
Chicago 3
Freiburg im Breisgau 3
Jiaxing 3
Las Vegas 3
Los Angeles 3
Naples 3
Paris 3
Ravenna 3
Vicenza 3
Wittnau 3
Abano Terme 2
Apex 2
Barcelona 2
Bologna 2
Budrio 2
Changsha 2
Dueville 2
Groningen 2
Hangzhou 2
Hanover 2
Heeze 2
Llubí 2
Messina 2
Modena 2
Oslo 2
Pavia 2
Québec 2
Redwood City 2
Siena 2
Stuttgart 2
Amsterdam 1
Boydton 1
Buffalo 1
Civitavecchia 1
Fremont 1
Fuzhou 1
Gorizia 1
Greifswald 1
Islington 1
Jakarta 1
Jinan 1
Jülich 1
Kish 1
Lanzhou 1
Mahé 1
Miami 1
Missaglia 1
Nagold 1
Pasian di Prato 1
Riyadh 1
Rockville 1
Rubano 1
Salò 1
Santa Maria a Monte 1
Scorzè 1
Singapore 1
Taizhou 1
Torrebelvicino 1
Venice 1
Totale 2246
Nome #
Overground robot assisted gait trainer for the treatment of drug-resistant freezing of gait in Parkinson disease 118
Cognitive profiling of Parkinson disease patients with mild cognitive impairment and dementia 97
MMSE and MoCA in Parkinson’s disease and dementia with Lewy bodies: a multicenter 1-year follow-up study 93
Brain structural profile of multiple system atrophy patients with cognitive impairment 93
Anatomical Correlates of Cognitive Functions in Early Parkinson's Disease Patients 89
Acceptability to patients, carers and clinicians of an mHealth platform for the management of Parkinson's disease (PD_Manager): study protocol for a pilot randomised controlled trial 86
Brain Amyloid Contribution to Cognitive Dysfunction in Early-Stage Parkinson's Disease: The PPMI Dataset 85
Characteristics and progression of cognitive deficits in progressive supranuclear palsy vs. multiple system atrophy and Parkinson's disease 83
Patterns of cortical thickness associated with impulse control disorders in Parkinson's disease 79
Dynamic functional connectivity changes associated with dementia in Parkinson's disease 78
Successful subthalamic stimulation in genetic Parkinson's disease caused by duplication of the α-synuclein gene. 75
Nonmotor Symptoms and Natural History of Parkinson's Disease: Evidence From Cognitive Dysfunction and Role of Noninvasive Interventions 70
Diagnostic and screening power of neuropsychological testing in detecting mild cognitive impairment in Parkinson's disease 69
Impulse control disorders in advanced Parkinson's disease with dyskinesia: The ALTHEA study 68
Impact of Cognitive Profile on Impulse Control Disorders Presence and Severity in Parkinson's Disease 68
Cognitive impairment in multiple system atrophy 64
tDCS effect on cognitive performance in Parkinson's disease 63
Anatomical profile of cognitive impairment in MSA 62
Double-blind randomized trial of t-DCS versus sham in Parkinson patients with mild cognitive impairment receiving cognitive training 59
Automated MRI Classification in Progressive Supranuclear Palsy: A Large International Cohort Study 58
Brain volume changes in Parkinson's disease and their relationship with cognitive and behavioural abnormalities 57
Reply: Dynamic functional connectivity changes in Lewy body disease 55
Impact of social and mobility restrictions in Parkinson's disease during COVID-19 lockdown 53
Cognitive Rehabilitation in Parkinson's Disease: Is it Feasible? 50
A New MRI Measure to Early Differentiate Progressive Supranuclear Palsy From De Novo Parkinson's Disease in Clinical Practice: An International Study 49
Differences in cognitive profiles between Lewy body and Parkinson’s disease dementia 49
Can dopamine transporter imaging define early PD? 42
Erratum: Double-blind Randomized Trial of tDCS Versus Sham in Parkinson Patients with Mild Cognitive Impairment Receiving Cognitive Training 41
MoCA vs. MMSE sensitivity as screening instruments of cognitive impairment in PD, MSA and PSP patients 41
Incentive-driven decision-making networks in de novo and drug-treated Parkinson's disease patients with impulsive-compulsive behaviors: A systematic review of neuroimaging studies 41
Asymmetric Dopamine Transporter Loss Affects Cognitive and Motor Progression in Parkinson's Disease 41
null 40
The contribution of beta-amyloid to dementia in Lewy body diseases: a 1-year follow-up study 37
Validation of the Italian version of the Movement Disorder Society - Unified Parkinson's Disease Rating Scale 36
The interplay between asymmetric dopaminergic degeneration, brain structural changes and cognition in de-novo PD: The PPMI dataset 33
Cognitive profiling in patients with Parkinson’s disease, multiple system atrophy and progressive supranuclear palsy: a 15-month longitudinal study 30
Safety and efficacy of cognitive rehabilitation in PD with cognitive impairments 29
Effect of Intensive Rehabilitation Program in Thermal Water on a Group of People with Parkinson’s Disease: A Retrospective Longitudinal Study 27
Brain structural abnormalities in multiple system atrophy patients with cognitive impairment 23
Non-invasive brain stimulation to treat cognitive symptoms of Parkinson's disease. Parkinsonism 23
Montreal Cognitive Assessment (MoCA) and Mini-Mental State Examination (MMSE) performance in progressive supranuclear palsy and multiple system atrophy 23
Multimodal PET/MRI Study of Connectivity in Cognitively Impaired Patients with Parkinson’s Disease 22
Early DEtection of wEaring off in Parkinson disease: the DEEP study 21
Detecting Mild Cognitive Deficits in Parkinson's Disease: Comparison of Neuropsychological Tests 20
Profile and progression of cognitive deficits in Progressive Supranuclear Palsy, Multiple System Atrophy and Parkinson's Disease 14
Quantification of Brain β-Amyloid Load in Parkinson's Disease With Mild Cognitive Impairment: A PET/MRI Study 14
The MTHFR C677T polymorphism modifies age at onset in Parkinson's disease 13
Action Selection and Motor Decision Making: Insights from Transcranial Magnetic Stimulation 12
MMSE and MoCA in Parkinson’s disease and dementia with Lewy bodies: a multicenter 1-year follow-up study 11
Neurocognitive correlates of numerical abilities in Parkinson’s disease 11
Long-term safety, discontinuation and mortality in an Italian cohort with advanced Parkinson's disease on levodopa/carbidopa intestinal gel infusion 11
Correction to: Long-term safety, discontinuation and mortality in an Italian cohort with advanced Parkinson’s disease on levodopa/carbidopa intestinal gel infusion (Journal of Neurology, (2022), 269, 10, (5606-5614), 10.1007/s00415-022-11269-7) 10
Language-specific effects in Alzheimer's disease: Subject omission in Italian and English 9
Reasons driving treatment modification in Parkinson's disease: results from the cross-sectional phase of the REASON study 9
Adherence to anti-Parkinson drug therapy in the "REASON" sample of Italian patients with Parkinson's disease: the linguistic validation of the Italian version of the "Morisky Medical Adherence Scale-8 items" 9
Role of genetic polymorphisms of the dopaminergic system in Parkinson's disease patients with impulse control disorders 9
Grey matter changes in cognitively impaired Parkinson's disease patients 8
Parkinson’s Disease 8
Cognitive and MRI correlates of orthostatic hypotension in Parkinson's disease 8
The neuroanatomical substrate of lexical-semantic decline in MCI APOE ε4 carriers and noncarriers 8
Brain volume changes in Parkinson's disease and their relationship with cognitive and behavioural abnormalities 8
Level I PD-MCI Using Global Cognitive Tests and the Risk for Parkinson's Disease Dementia 8
Anatomical and functional correlates of persistent pain in Parkinson's disease 7
Diagnostic and screening power of neuropsychological testing in detecting mild cognitive impairment in Parkinson's disease 7
Acceptability to patients, carers and clinicians of an mHealth platform for the management of Parkinson's disease (PD_Manager): study protocol for a pilot randomised controlled trial 7
Long-Term Cognitive Decline in Dementia with Lewy Bodies in a Large Multicenter, International Cohort. 7
CSF tau proteins correlate with an atypical clinical presentation in dementia with Lewy bodies 7
Heart rate circadian profile in the differential diagnosis between Parkinson disease and multiple system atrophy 6
Duodenal alpha-Synuclein Pathology and Enteric Gliosis in Advanced Parkinson's Disease 5
Clinical, cognitive, and morphometric profiles of progressive supranuclear palsy phenotypes 5
Development and Validation of Automated Magnetic Resonance Parkinsonism Index 2.0 to Distinguish Progressive Supranuclear Palsy-Parkinsonism From Parkinson's Disease 4
Can dopamine transporter imaging define early PD? 4
Influence of APOE status on lexical-semantic skills in mild cognitive impairment 4
Performance at the Category-Exemplars language test (CATEX) in Parkinson's disease and Huntington's disease Italian population 4
null 4
null 3
Subject drop in Italian Alzheimer's disease 3
A case of childhood-onset dystonia-parkinsonism due to homozygous parkin mutations and effect of globus pallidus deep brain stimulation 3
Diagnosing dementia in multiple system atrophy by applying Movement Disorder Society diagnostic criteria for Parkinson's disease dementia 3
Therapy-resistant symptoms in Parkinson's disease. 3
Identification of circulating microRNAs for the differential diagnosis of Parkinson's disease and Multiple System Atrophy 3
Clinical trials for cognition in Parkinson's disease: Where are we and how can we do better? 3
Erratum: Double-blind Randomized Trial of tDCS Versus Sham in Parkinson Patients with Mild Cognitive Impairment Receiving Cognitive Training (Brain Stimulation (2015) 8 (1223-1225) DOI: 10.1016/j.brs.2015.07.043) 3
Overground robot assisted gait trainer for the treatment of drug-resistant freezing of gait in Parkinson disease 2
Management of psychiatric and cognitive complications in Parkinson's disease 2
Correction to: A case of childhood‑onset dystonia‑parkinsonism due to homozygous parkin mutations and effect of globus pallidus deep brain stimulation 1
Validation of the Italian version of Parkinson's disease-cognitive rating scale (PD-CRS) 1
Personalized Care in Late-Stage Parkinson's Disease: Challenges and Opportunities 1
Cognitive decline in Parkinson's disease: the complex picture 1
Totale 2723
Categoria #
all - tutte 8728
article - articoli 7664
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 163
Totale 16555


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019161 4051 13 06 0276450
2019/2020458 4738127 6134 4655 67353710
2020/2021476 2210918 1270 3726 514210277
2021/2022753 135464335 15120 3145 327939133
2022/2023749 8295761 117102 3115 1128803
Totale 2723